ValuentumAd

Official PayPal Seal
Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Aug 3, 2013
Procter & Gamble’s Fourth Quarter Reveals Lafley’s Strategy
P&G’s new (and old) CEO has us excited about the firm’s dividend growth trajectory.
Aug 2, 2013
DirecTV’s “Miss” Mostly a Currency Issue
DirecTV is a cash cow, and we expect consolidation to benefit the industry.
Aug 2, 2013
Valuentum's August Edition of Its Dividend Growth Newsletter
The August edition of our Dividend Growth Newsletter is now available.
Aug 1, 2013
Teva Boasts a Several Billion Dollar NTE Opportunity
Revenue potential from the launch of new therapeutic entities (NTEs) in coming years should more than offset troubles from the loss of exclusivity of Copaxone.
Aug 1, 2013
Regulatory Uncertainty Once Again Strikes Visa and MasterCard
Last time regulatory uncertainty struck it provided a wonderful entry point for Visa. Will history repeat itself?
Aug 1, 2013
Digging into Phillips 66’s Results: Earnings Decline Not Tragic
Extraneous events caused headaches for Phillips 66 during the second quarter, but we think the company remains well-positioned over the long haul.
Aug 1, 2013
Pfizer and Merck Show Revenue Declines; Pipelines Remain Strong
Pfizer and Merck faced key patent expirations in the second quarter. However, both of their respective pipelines are promising.
Aug 1, 2013
Newmont Suffers from Weak Gold Prices; Underscores Industry Troubles
Newmont Mining is working to reduce costs, but revenue is falling at a slightly faster pace.
Jul 31, 2013
Amgen’s Second Quarter Doesn’t Disappoint
Amgen posted a solid second quarter, but we think shares look fairly valued.
Jul 31, 2013
Utilization Drives Record Profit at TAL International
The intermodal container lessor continues to capitalize on its low-risk leasing model despite a modest shipping environment.


The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.